Biodesix Common Stock Shares Outstanding vs Long Term Debt Analysis

BDSX Stock

USD 0.83 0.03 3.96%

Biodesix financial indicator trend analysis is way more than just evaluating Biodesix prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biodesix is a good investment. Please check the relationship between Biodesix Common Stock Shares Outstanding and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Common Stock Shares Outstanding vs Long Term Debt

Common Stock Shares Outstanding vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biodesix Common Stock Shares Outstanding account and Long Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Biodesix's Common Stock Shares Outstanding and Long Term Debt is 0.64. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Biodesix, assuming nothing else is changed. The correlation between historical values of Biodesix's Common Stock Shares Outstanding and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Biodesix are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Common Stock Shares Outstanding i.e., Biodesix's Common Stock Shares Outstanding and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Long Term Debt

Long-term debt is a debt that Biodesix has held for over one year. Long-term debt appears on Biodesix balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Biodesix balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Biodesix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biodesix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.Selling General Administrative is likely to drop to about 49.7 M in 2025. Issuance Of Capital Stock is likely to drop to about 41 M in 2025

	2024	2025 (projected)
Depreciation And Amortization	6.3M	3.2M
Interest Income	16.2K	25.9K

Depreciation And Amortization Interest Income

Biodesix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.6	0.76	0.92	0.95	-0.43	0.95	0.68	0.46	-0.34	-0.83	0.8	0.93	0.76	0.86	0.88	0.27	0.93	0.89	0.95	0.94	0.66	-0.94	0.8	0.98	0.98
Short Long Term Debt Total	0.6		0.79	0.65	0.51	-0.47	0.55	0.96	-0.27	0.52	-0.79	0.34	0.34	0.82	0.87	0.83	0.74	0.34	0.52	0.66	0.63	0.89	-0.47	0.19	0.53	0.59
Other Current Liab	0.76	0.79		0.84	0.81	-0.8	0.84	0.92	-0.04	0.12	-0.94	0.34	0.58	0.82	0.91	0.89	0.4	0.58	0.52	0.89	0.89	0.87	-0.82	0.57	0.77	0.82
Total Current Liabilities	0.92	0.65	0.84		0.88	-0.47	0.89	0.71	0.42	-0.19	-0.85	0.68	0.8	0.77	0.82	0.82	0.27	0.8	0.83	0.95	0.91	0.6	-0.89	0.77	0.92	0.92
Total Stockholder Equity	0.95	0.51	0.81	0.88		-0.58	1.0	0.66	0.43	-0.42	-0.86	0.68	0.93	0.67	0.85	0.87	0.1	0.93	0.76	0.95	0.98	0.65	-0.99	0.86	0.96	0.97
Other Liab	-0.43	-0.47	-0.8	-0.47	-0.58		-0.6	-0.67	0.38	-0.13	0.74	0.17	-0.26	-0.65	-0.66	-0.65	-0.37	-0.26	0.0	-0.63	-0.63	-0.71	0.61	-0.24	-0.43	-0.58
Net Tangible Assets	0.95	0.55	0.84	0.89	1.0	-0.6		0.69	0.39	-0.38	-0.88	0.67	0.92	0.7	0.87	0.89	0.14	0.92	0.76	0.96	0.99	0.68	-0.99	0.84	0.96	0.98
Property Plant And Equipment Net	0.68	0.96	0.92	0.71	0.66	-0.67	0.69		-0.25	0.4	-0.89	0.32	0.43	0.87	0.92	0.89	0.66	0.43	0.5	0.77	0.76	0.97	-0.63	0.33	0.64	0.71
Current Deferred Revenue	0.46	-0.27	-0.04	0.42	0.43	0.38	0.39	-0.25		-0.83	0.0	0.76	0.68	-0.14	0.0	0.05	-0.58	0.68	0.66	0.32	0.33	-0.31	-0.43	0.76	0.53	0.37
Net Debt	-0.34	0.52	0.12	-0.19	-0.42	-0.13	-0.38	0.4	-0.83		-0.06	-0.47	-0.62	0.26	0.08	0.02	0.7	-0.62	-0.34	-0.23	-0.28	0.35	0.44	-0.67	-0.41	-0.32
Retained Earnings	-0.83	-0.79	-0.94	-0.85	-0.86	0.74	-0.88	-0.89	0.0	-0.06		-0.4	-0.67	-0.83	-0.96	-0.96	-0.46	-0.67	-0.58	-0.9	-0.92	-0.84	0.86	-0.54	-0.79	-0.88
Accounts Payable	0.8	0.34	0.34	0.68	0.68	0.17	0.67	0.32	0.76	-0.47	-0.4		0.84	0.37	0.5	0.52	-0.04	0.84	0.96	0.63	0.64	0.28	-0.63	0.79	0.81	0.68
Cash	0.93	0.34	0.58	0.8	0.93	-0.26	0.92	0.43	0.68	-0.62	-0.67	0.84		0.47	0.7	0.74	-0.08	1.0	0.86	0.85	0.88	0.42	-0.91	0.9	0.93	0.89
Non Current Assets Total	0.76	0.82	0.82	0.77	0.67	-0.65	0.7	0.87	-0.14	0.26	-0.83	0.37	0.47		0.85	0.83	0.77	0.47	0.56	0.81	0.73	0.85	-0.68	0.33	0.7	0.8
Non Currrent Assets Other	0.86	0.87	0.91	0.82	0.85	-0.66	0.87	0.92	0.0	0.08	-0.96	0.5	0.7	0.85		1.0	0.53	0.7	0.66	0.9	0.91	0.91	-0.82	0.52	0.81	0.88
Other Assets	0.88	0.83	0.89	0.82	0.87	-0.65	0.89	0.89	0.05	0.02	-0.96	0.52	0.74	0.83	1.0		0.49	0.74	0.68	0.91	0.92	0.88	-0.84	0.55	0.82	0.9
Long Term Debt	0.27	0.74	0.4	0.27	0.1	-0.37	0.14	0.66	-0.58	0.7	-0.46	-0.04	-0.08	0.77	0.53	0.49		-0.08	0.14	0.3	0.19	0.64	-0.09	-0.32	0.13	0.28
Cash And Short Term Investments	0.93	0.34	0.58	0.8	0.93	-0.26	0.92	0.43	0.68	-0.62	-0.67	0.84	1.0	0.47	0.7	0.74	-0.08		0.86	0.85	0.88	0.42	-0.91	0.9	0.93	0.89
Net Receivables	0.89	0.52	0.52	0.83	0.76	0.0	0.76	0.5	0.66	-0.34	-0.58	0.96	0.86	0.56	0.66	0.68	0.14	0.86		0.77	0.75	0.43	-0.73	0.77	0.88	0.8
Good Will	0.95	0.66	0.89	0.95	0.95	-0.63	0.96	0.77	0.32	-0.23	-0.9	0.63	0.85	0.81	0.9	0.91	0.3	0.85	0.77		0.98	0.72	-0.96	0.77	0.95	0.98
Common Stock Total Equity	0.94	0.63	0.89	0.91	0.98	-0.63	0.99	0.76	0.33	-0.28	-0.92	0.64	0.88	0.73	0.91	0.92	0.19	0.88	0.75	0.98		0.74	-0.98	0.81	0.95	0.97
Common Stock Shares Outstanding	0.66	0.89	0.87	0.6	0.65	-0.71	0.68	0.97	-0.31	0.35	-0.84	0.28	0.42	0.85	0.91	0.88	0.64	0.42	0.43	0.72	0.74		-0.62	0.3	0.61	0.69
Non Current Liabilities Total	-0.94	-0.47	-0.82	-0.89	-0.99	0.61	-0.99	-0.63	-0.43	0.44	0.86	-0.63	-0.91	-0.68	-0.82	-0.84	-0.09	-0.91	-0.73	-0.96	-0.98	-0.62		-0.86	-0.96	-0.97
Inventory	0.8	0.19	0.57	0.77	0.86	-0.24	0.84	0.33	0.76	-0.67	-0.54	0.79	0.9	0.33	0.52	0.55	-0.32	0.9	0.77	0.77	0.81	0.3	-0.86		0.89	0.78
Other Current Assets	0.98	0.53	0.77	0.92	0.96	-0.43	0.96	0.64	0.53	-0.41	-0.79	0.81	0.93	0.7	0.81	0.82	0.13	0.93	0.88	0.95	0.95	0.61	-0.96	0.89		0.97
Other Stockholder Equity	0.98	0.59	0.82	0.92	0.97	-0.58	0.98	0.71	0.37	-0.32	-0.88	0.68	0.89	0.8	0.88	0.9	0.28	0.89	0.8	0.98	0.97	0.69	-0.97	0.78	0.97

Click cells to compare fundamentals

Biodesix Account Relationship Matchups

Biodesix fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	121.1M	76.1M	92.9M	99.1M	114.0M	86.1M
Short Long Term Debt Total	27.8M	10.0M	31.9M	60.7M	69.8M	73.3M
Other Current Liab	7.8M	25.4M	17.1M	29.9M	34.3M	36.1M
Total Current Liabilities	32.1M	29.0M	22.8M	33.4M	38.4M	26.5M
Total Stockholder Equity	41.2M	19.7M	20.6M	4.6M	5.3M	5.5M
Other Liab	29.8M	31.9M	17.4M	19.2M	17.3M	19.8M
Net Tangible Assets	(255.3M)	12.9M	(6.9M)	(4.2M)	(4.9M)	(5.1M)
Property Plant And Equipment Net	3.2M	4.2M	8.8M	29.6M	34.1M	35.8M
Current Deferred Revenue	3.5M	1.9M	962K	324K	291.6K	277.0K
Net Debt	(34.4M)	(22.7M)	(11.2M)	34.4M	31.0M	32.5M
Retained Earnings	(258.8M)	(302.0M)	(367.4M)	(419.6M)	(377.6M)	(396.5M)
Accounts Payable	9.0M	1.7M	1.7M	2.9M	3.4M	3.3M
Cash	62.1M	32.7M	43.1M	26.3M	30.2M	32.2M
Non Current Assets Total	34.9M	32.5M	39.6M	59.4M	68.3M	41.2M
Non Currrent Assets Other	3.5M	1.7M	5.9M	6.9M	7.9M	8.3M
Other Assets	90K	3.5M	1.7M	5.9M	6.8M	7.2M
Long Term Debt	15.9M	10.0M	25.0M	35.2M	40.5M	24.4M
Cash And Short Term Investments	62.1M	32.7M	43.1M	26.3M	30.2M	32.2M
Net Receivables	15.3M	3.7M	5.1M	7.7M	8.8M	7.1M
Common Stock Shares Outstanding	26.6M	27.4M	42.1M	82.1M	94.4M	99.2M
Liabilities And Stockholders Equity	121.1M	76.1M	92.9M	99.1M	114.0M	86.1M
Non Current Liabilities Total	47.8M	27.4M	49.5M	61.1M	55.0M	88.8M
Inventory	800K	3.2M	2.9M	1.4M	1.6M	1.9M
Other Current Assets	5.5M	4.3M	3.8M	4.3M	5.0M	4.1M
Other Stockholder Equity	421.0M	321.7M	387.9M	424.1M	487.7M	286.9M
Total Liab	79.9M	56.4M	72.3M	94.5M	85.1M	108.0M
Net Invested Capital	68.9M	29.7M	45.7M	39.9M	45.8M	48.1M
Property Plant And Equipment Gross	3.2M	4.2M	8.8M	35.2M	40.5M	42.5M
Total Current Assets	86.1M	43.6M	53.3M	39.7M	45.6M	45.0M
Capital Stock	27K	31K	78K	96K	110.4K	115.9K
Non Current Liabilities Other	31.9M	17.4M	19.2M	712K	640.8K	608.8K
Net Working Capital	54.0M	14.7M	30.5M	6.3M	7.2M	6.8M
Intangible Assets	13.3M	11.6M	9.8M	7.9M	7.1M	9.9M
Common Stock	27K	31K	78K	96K	110.4K	115.9K
Property Plant Equipment	2.1M	3.2M	4.2M	8.8M	10.1M	10.7M
Short Long Term Debt	11.8M	19K	49K	51K	45.9K	43.6K
Short Term Debt	11.8M	19K	3.1M	303K	272.7K	259.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biodesix Common Stock Shares Outstanding vs Long Term Debt Analysis

Common Stock Shares Outstanding vs Long Term Debt

Common Stock Shares Outstanding vs Long Term Debt Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Long Term Debt

Biodesix fundamental ratios Correlations

Biodesix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biodesix fundamental ratios Accounts

Also Currently Popular

Additional Tools for Biodesix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Other Assets	+ 1.0	Non Currrent Assets Other
Common Stock Total Equity	+ 0.99	Net Tangible Assets
Other Current Assets	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.98	Total Assets

Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Non Current Liabilities Total	- 0.98	Common Stock Total Equity
Other Stockholder Equity	- 0.97	Non Current Liabilities Total
Other Current Assets	- 0.96	Non Current Liabilities Total
Non Current Liabilities Total	- 0.96	Good Will